X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (34) 34
index medicus (28) 28
animals (25) 25
child (19) 19
female (19) 19
male (19) 19
mice (19) 19
neurosciences (17) 17
pediatrics (17) 17
clinical neurology (15) 15
children (14) 14
child, preschool (11) 11
gene expression (11) 11
genetic vectors (11) 11
adolescent (10) 10
gene transfer techniques (10) 10
genetics (10) 10
genetics & heredity (10) 10
mutation (10) 10
neurology (10) 10
article (9) 9
expression (9) 9
rats (8) 8
spinal muscular atrophy (8) 8
beta-galactosidase - genetics (7) 7
cells, cultured (7) 7
clinical trials (7) 7
luciferases - genetics (7) 7
phenotype (7) 7
skeletal-muscle (7) 7
adenoviruses, human - genetics (6) 6
charcot-marie-tooth disease (6) 6
dna (6) 6
dystrophin - genetics (6) 6
gene therapy (6) 6
medicine (6) 6
molecular sequence data (6) 6
research (6) 6
transfection (6) 6
treatment outcome (6) 6
valproic acid - therapeutic use (6) 6
adenoviridae - genetics (5) 5
age (5) 5
carnitine (5) 5
cells (5) 5
cohort studies (5) 5
divalproex (5) 5
dystrophin (5) 5
infant (5) 5
invivo (5) 5
medical research (5) 5
medicine, research & experimental (5) 5
minidystrophin gene (5) 5
muscular atrophy, spinal - genetics (5) 5
plasmids (5) 5
reliability (5) 5
science (5) 5
smn protein (5) 5
valproic acid (5) 5
young adult (5) 5
abridged index medicus (4) 4
acids (4) 4
apoptosis (4) 4
atrophy (4) 4
base sequence (4) 4
beta-galactosidase - biosynthesis (4) 4
beta-galactosidase - metabolism (4) 4
biochemistry & molecular biology (4) 4
biology (4) 4
carnitine - therapeutic use (4) 4
charcot-marie-tooth disease - physiopathology (4) 4
genetic aspects (4) 4
genetic therapy (4) 4
health aspects (4) 4
mdx mice (4) 4
mice, inbred balb c (4) 4
mice, inbred mdx (4) 4
mouse (4) 4
multidisciplinary sciences (4) 4
muscular atrophy, spinal - drug therapy (4) 4
muscular atrophy, spinal - physiopathology (4) 4
muscular dystrophy (4) 4
nerve tissue proteins - genetics (4) 4
physiological aspects (4) 4
proteins (4) 4
quality of life (4) 4
research article (4) 4
rodents (4) 4
survival (4) 4
time factors (4) 4
valproic acid - adverse effects (4) 4
vectors (4) 4
action potential (3) 3
adenoviral vector (3) 3
adult (3) 3
age factors (3) 3
avian sarcoma viruses - genetics (3) 3
biotechnology & applied microbiology (3) 3
carnitine - adverse effects (3) 3
charcot-marie-tooth disease - diagnosis (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Pediatric Neurology, ISSN 1304-2580, 09/2010, Volume 8, Issue 3, pp. 243 - 244
  In order to achieve evidence-based medical care for pediatric stroke, more research and large multi-center collaborative studies are needed. Since the first... 
Foreword | Medical research | Medical imaging | Colleges & universities
Journal Article
Pediatric Clinics of North America, ISSN 0031-3955, 06/2015, Volume 62, Issue 3, pp. xvii - xviii
Journal Article
Annals of Neurology, ISSN 0364-5134, 10/2011, Volume 70, Issue 4, pp. 662 - 665
The prevalence of congenital myopathies in the United States has not been examined. To address this, we determined the point prevalence of congenital... 
NEUROSCIENCES | CLINICAL NEUROLOGY | DISEASE | United States - epidemiology | Prevalence | Ryanodine Receptor Calcium Release Channel - genetics | Muscular Dystrophies - epidemiology | Humans | Female | Male | Mutation | Michigan - epidemiology | Muscular Dystrophies - genetics | Child | Smoking cessation | Transdermal medication
Journal Article
Pediatric Neurology, ISSN 0887-8994, 2013, Volume 48, Issue 2, pp. 95 - 104
Journal Article
Pediatric Neurology, ISSN 0887-8994, 02/2013, Volume 48, Issue 2, pp. 95 - 104
Juvenile myasthenia gravis is an uncommon autoimmune disorder. Its management is not standardized. Juvenile myasthenia gravis is pathophysiologically similar... 
Myasthenia gravis | Races | Reviews | Antibodies | Neuromuscular junctions | Autoimmune diseases | Age
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 8, p. e12140
Background: Valproic acid (VPA) has demonstrated potential as a therapeutic candidate for spinal muscular atrophy (SMA) in vitro and in vivo. Methods: Two... 
GENE | PROTEIN-LEVEL | BIOLOGY | INCREASES | PHENOTYPE | FUNCTIONAL MOTOR SCALE | RELIABILITY | HAND-HELD DYNAMOMETRY | SMN2 COPY NUMBER | MODEL MICE | CHILDREN | Motor Activity - physiology | Age Factors | Humans | Body Weight - drug effects | Child, Preschool | Motor Activity - drug effects | Infant | Male | RNA, Messenger - metabolism | Valproic Acid - pharmacology | Muscular Atrophy, Spinal - genetics | Body Composition - drug effects | Carnitine - pharmacology | Drug-Related Side Effects and Adverse Reactions | Survival of Motor Neuron 1 Protein - genetics | Female | Valproic Acid - therapeutic use | Valproic Acid - adverse effects | Child | Muscular Atrophy, Spinal - physiopathology | Body Mass Index | Double-Blind Method | RNA, Messenger - genetics | Treatment Outcome | Lung - physiopathology | Gene Expression Regulation - drug effects | Carnitine - adverse effects | Bone Density - drug effects | Lung - drug effects | Carnitine - therapeutic use | Quality of Life | Muscular Atrophy, Spinal - drug therapy | Cohort Studies | Electrophysiological Phenomena - drug effects | Survival of Motor Neuron 1 Protein - blood | Divalproex | RNA | Analysis | Clinical trials | Levocarnitine | Research | Valproic acid | Health aspects | Spinal muscular atrophy | Health care | Pediatrics | Body fat | SMN protein | mRNA | Muscular dystrophy | Body composition | Proteins | Atrophy | Randomization | Motivation | Body composition (biology) | Safety engineering | Rodents | L-Carnitine | Children | Age | Regression analysis | Carnitine | Quality of life | Medicine | Neurology | Acids | In vivo methods and tests | In vitro methods and tests
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2009, Volume 4, Issue 5, pp. e5268 - e5268
Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased... 
BIOLOGY | Humans | Child, Preschool | Electrophysiology | Valproic Acid - pharmacology | Enzyme Inhibitors - administration & dosage | Young Adult | Muscular Atrophy, Spinal - genetics | Body Composition - drug effects | Survival of Motor Neuron 2 Protein - genetics | Adult | Valproic Acid - therapeutic use | Valproic Acid - adverse effects | Child | Enzyme Inhibitors - adverse effects | Enzyme Inhibitors - pharmacology | Treatment Outcome | Absorptiometry, Photon | Enzyme Inhibitors - therapeutic use | Muscular Atrophy, Spinal - pathology | Bone Density - drug effects | Neurologic Examination | Valproic Acid - administration & dosage | Analysis of Variance | Adolescent | Muscular Atrophy, Spinal - drug therapy | Respiratory Function Tests | Medical research | Divalproex | RNA | Clinical trials | Medicine, Experimental | Bones | Product development | Valproic acid | Health aspects | Density | Spinal muscular atrophy | Carnitine | Pediatrics | Cerebral palsy | Body fat | SMN protein | Innervation | Action potential | mRNA | Body composition | Proteins | Atrophy | Salt | Body composition (biology) | Rodents | Safety engineering | Bone density | Oxidation | Hepatotoxicity | Bone composition | Age | Dual energy X-ray absorptiometry | Departments | Metabolism | Fatty acids | Medicine | Human subjects | Neurology | Pathology | Depletion | Acids | Cell lines | Bone mineral density | In vivo methods and tests | Bone | Index Medicus
Journal Article
Journal Article
Journal Article
Nature Genetics, ISSN 1061-4036, 05/2013, Volume 45, Issue 5, pp. 556 - 562
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0127045
Journal Article
Journal of Pediatric Neurology, ISSN 1304-2580, 2010, Volume 8, Issue 3, pp. 243 - 244
Journal Article